Martín-Antonio B

ORCID: 0000-0003-0612-2693 · 1 paper in corpus
2021
Frontiers in immunology ·doi:10.3389/fimmu.2021.717850

Adoptive cellular immunotherapy using chimeric antigen receptor (CAR)-modified T cells and Natural Killer (NK) cells are common immune cell sources administered to treat cancer patients. In detail, whereas CAR-T cells induce outstanding res…